• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Safety and effectiveness of introducing a robotic-assisted percutaneous coronary intervention program in a tertiary center: a prospective study.在三级医疗中心引入机器人辅助经皮冠状动脉介入治疗项目的安全性和有效性:一项前瞻性研究。
Cardiovasc Diagn Ther. 2022 Feb;12(1):67-76. doi: 10.21037/cdt-21-442.
2
Robotic-assisted percutaneous coronary intervention: experience in Switzerland.机器人辅助经皮冠状动脉介入治疗:瑞士的经验
Front Cardiovasc Med. 2023 Dec 4;10:1294930. doi: 10.3389/fcvm.2023.1294930. eCollection 2023.
3
First-in-human evaluation of a novel robotic-assisted coronary angioplasty system.首例新型机器人辅助冠状动脉成形术系统的人体评估。
JACC Cardiovasc Interv. 2011 Apr;4(4):460-5. doi: 10.1016/j.jcin.2010.12.007.
4
Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the CORA-PCI Study (Complex Robotically Assisted Percutaneous Coronary Intervention).机器人辅助经皮冠状动脉介入治疗复杂冠状动脉病变的安全性和可行性研究:CORA-PCI 研究结果(复杂机器人辅助经皮冠状动脉介入治疗)。
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1320-1327. doi: 10.1016/j.jcin.2017.03.050.
5
Establishing a robotic-assisted PCI program: experiences at a large tertiary referral center.建立机器人辅助 PCI 项目:一家大型三级转诊中心的经验。
Heart Vessels. 2022 Oct;37(10):1669-1678. doi: 10.1007/s00380-022-02078-z. Epub 2022 Apr 29.
6
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study.机器人经皮冠状动脉介入治疗的安全性和可行性:PRECISE(经皮机器人增强冠状动脉介入治疗)研究。
J Am Coll Cardiol. 2013 Apr 16;61(15):1596-600. doi: 10.1016/j.jacc.2012.12.045.
7
Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience.远程机器人辅助经皮冠状动脉介入治疗:首例人体经验报告。
EClinicalMedicine. 2019 Sep 3;14:53-58. doi: 10.1016/j.eclinm.2019.07.017. eCollection 2019 Sep.
8
[Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].药物涂层球囊血管成形术或药物洗脱支架置入术对急性心肌梗死合并初发冠状动脉病变患者进行直接经皮冠状动脉介入治疗的疗效比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):600-607. doi: 10.3760/cma.j.cn112148-20200327-00254.
9
Robotically-assisted percutaneous coronary intervention: Reasons for partial manual assistance or manual conversion.机器人辅助经皮冠状动脉介入治疗:部分手动辅助或手动转换的原因。
Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):526-531. doi: 10.1016/j.carrev.2017.11.003. Epub 2017 Nov 9.
10
Implementation of Robotic-Assisted Percutaneous Coronary Intervention Into a High-Risk PCI Program.机器人辅助经皮冠状动脉介入治疗在高危 PCI 项目中的应用。
Cardiovasc Revasc Med. 2022 Oct;43:115-119. doi: 10.1016/j.carrev.2022.05.022. Epub 2022 May 18.

引用本文的文献

1
Features and Limitations of Robotically Assisted Percutaneous Coronary Intervention (R-PCI): A Systematic Review of R-PCI.机器人辅助经皮冠状动脉介入治疗(R-PCI)的特点与局限性:R-PCI的系统评价
J Clin Med. 2024 Sep 19;13(18):5537. doi: 10.3390/jcm13185537.
2
Robotic-assisted percutaneous coronary intervention: experience in Switzerland.机器人辅助经皮冠状动脉介入治疗:瑞士的经验
Front Cardiovasc Med. 2023 Dec 4;10:1294930. doi: 10.3389/fcvm.2023.1294930. eCollection 2023.
3
Robotic percutaneous coronary intervention (R-PCI): Time to focus on the pros and cons.机器人经皮冠状动脉介入治疗(R-PCI):是时候关注利弊了。
Indian Heart J. 2023 May-Jun;75(3):161-168. doi: 10.1016/j.ihj.2023.04.002. Epub 2023 Apr 18.

本文引用的文献

1
Use of robotic assistance to reduce proximity and air-sharing during percutaneous cardiovascular intervention.
Future Cardiol. 2021 Aug;17(5):865-873. doi: 10.2217/fca-2021-0024. Epub 2021 Apr 9.
2
Robotic-assisted intervention strategy to minimize air exposure during the procedure: a case report of myocardial infarction and COVID-19.在手术过程中尽量减少空气暴露的机器人辅助干预策略:心肌梗死合并新型冠状病毒肺炎的病例报告
Cardiovasc Diagn Ther. 2020 Oct;10(5):1345-1351. doi: 10.21037/cdt-20-521.
3
Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.围术期心肌梗死对血运重建后结局的影响。
J Am Coll Cardiol. 2020 Oct 6;76(14):1622-1639. doi: 10.1016/j.jacc.2020.08.009.
4
Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization.多支冠状动脉疾病非 ST 段抬高型心肌梗死的最佳血运重建策略:罪犯血管血运重建与一期/多期血运重建比较。
J Am Heart Assoc. 2020 Aug 4;9(15):e016575. doi: 10.1161/JAHA.120.016575. Epub 2020 Jul 31.
5
Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry).当代经皮冠状动脉介入治疗(PC I)穿孔的趋势、预测因素和结局(来自 NCDR Cath PCI 注册研究)。
Am J Cardiol. 2020 Sep 1;130:37-45. doi: 10.1016/j.amjcard.2020.06.014. Epub 2020 Jun 17.
6
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎(COVID-19)大流行期间的心导管实验室考量:来自美国心脏病学会介入委员会和心血管造影和介入学会
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.
7
In-hospital outcomes of delayed stenting in hemodynamically stable patients with ST-segment elevation myocardial infarction: the CCC (Care for Cardiovascular Disease in China) project.ST段抬高型心肌梗死血流动力学稳定患者延迟支架置入的院内结局:中国心血管疾病关爱(CCC)项目
Cardiovasc Diagn Ther. 2019 Oct;9(5):462-471. doi: 10.21037/cdt.2019.08.10.
8
Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience.远程机器人辅助经皮冠状动脉介入治疗:首例人体经验报告。
EClinicalMedicine. 2019 Sep 3;14:53-58. doi: 10.1016/j.eclinm.2019.07.017. eCollection 2019 Sep.
9
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
Glob Heart. 2018 Dec;13(4):305-338. doi: 10.1016/j.gheart.2018.08.004. Epub 2018 Aug 25.
10
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.经皮冠状动脉介入治疗临床试验的标准化终点定义:学术研究联合会-2 共识文件。
Circulation. 2018 Jun 12;137(24):2635-2650. doi: 10.1161/CIRCULATIONAHA.117.029289.

在三级医疗中心引入机器人辅助经皮冠状动脉介入治疗项目的安全性和有效性:一项前瞻性研究。

Safety and effectiveness of introducing a robotic-assisted percutaneous coronary intervention program in a tertiary center: a prospective study.

作者信息

Lemos Pedro A, Franken Marcelo, Mariani Jose, Caixeta Adriano, Almeida Breno O, Pitta Fabio G, Prado Guy F A, Garzon Stefano, Ramalho Felipe, Albuquerque Gabriel, Gomes Ivanise M, de Oliveira Irisvaldo S, Valle Leonardo, Galastri Leonardo, Affonso Breno B, Nasser Felipe, Garcia Rodrigo G

机构信息

Interventional Cardiology Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

出版信息

Cardiovasc Diagn Ther. 2022 Feb;12(1):67-76. doi: 10.21037/cdt-21-442.

DOI:10.21037/cdt-21-442
PMID:35282671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8898692/
Abstract

BACKGROUND

Robotic-assisted percutaneous coronary intervention (PCI) is a novel technology that permits remote operation of interventional devices. However, little is known about the safety and effectiveness of introducing a robotic PCI program in a hospital already experienced in traditional coronary angioplasty.

METHODS

Prospective single-arm survey to assess the safety and effectiveness of robotic-assisted PCI in comparison to pre-defined performance goals. The study cohort comprised all consecutive cases treated with robotic PCI since its introduction. The safety primary endpoint was a composite of (I) overall death or (II) non-fatal adverse events related to target vessel complications (stent thrombosis, myocardial infarction, vessel perforation or cardiac tamponade, or repeat invasive treatment) during the index hospitalization. The efficacy primary endpoint was robotic-assisted procedural success, a composite of (I) successful dilatation of the target lesion and (II) successful robotic assistance, defined as absent non-planned manual conversion.

RESULTS

A total of 83 patients and 112 lesions were prospectively enrolled. The rate of angiographic success was 99.1%. From these, 97 lesions (86.6%) were treated with only robotic PCI or with hybrid according to the pre-interventional plan. The rates of efficacy and safety primary endpoints were 85.7% and 2.4% respectively (P<0.01 for non-inferior to the pre-defined performance threshold).

CONCLUSIONS

Introduction of robotic-assisted PCI in a tertiary center was associated with safe and effective results, comparable to pre-defined goals of optimal performance.

摘要

背景

机器人辅助经皮冠状动脉介入治疗(PCI)是一种允许对介入设备进行远程操作的新技术。然而,对于在已经开展传统冠状动脉血管成形术的医院引入机器人PCI项目的安全性和有效性,人们知之甚少。

方法

进行前瞻性单臂调查,以评估机器人辅助PCI相对于预先设定的性能目标的安全性和有效性。研究队列包括自引入机器人PCI以来接受治疗的所有连续病例。安全主要终点是以下两者的综合:(I)总体死亡或(II)与靶血管并发症(支架血栓形成、心肌梗死、血管穿孔或心脏压塞,或重复侵入性治疗)相关的非致命不良事件,发生在首次住院期间。疗效主要终点是机器人辅助手术成功,其综合了以下两者:(I)靶病变成功扩张和(II)成功的机器人辅助,定义为无计划外手动转换。

结果

共前瞻性纳入83例患者和112个病变。血管造影成功率为99.1%。其中,97个病变(86.6%)根据介入前计划仅接受机器人PCI或混合治疗。疗效和安全主要终点的发生率分别为85.7%和2.4%(不劣于预先设定的性能阈值,P<0.01)。

结论

在三级中心引入机器人辅助PCI取得了安全有效的结果,与预先设定的最佳性能目标相当。